Failed to register as Favorite Page
Failed to cancel as Favorite Page
This page is already registered as a Favorite Page
You can't add your company to your favorites.

Latest update: 20/02/2018 02:07:33

Chromocenter Co., Ltd.


Other presentation

[Company strength]
Our company possesses an artificial chromosome vector that can freely carry an enormous number of genes. We have used this vector to enhance CHO cells for biomedical production. We also possess the world's top-level technology for reducing the cell preparation period. This is an essential technology for the bioeconomy, which is a global trend of the future. We now lead the world in chromosome analysis to evaluate iPS and other cells. We are devoted to constant product development to also become the world's leading company in the chromosome analysis of various other cells.

[Business description]
We apply our unique artificial chromosome vector to provide consignment services in enhancing CHO cells for biomedical production. We also make use of our cell evaluation technology to provide consignment analysis of the chromosomes of various cells, such as iPS cells, ES cells, and substance-producing cells. Our new business is to develop and provide substance-producing cells other than pharmaceuticals.

Service industry

[Representative's message]
Western technologies are dominant in the biomedical production driving the bioeconomy field. These technologies also seem applicable to high-level proteins in the field of industrial substance production, which will grow in the future. In can be said that the one who controls cells controls the market. Our company will find a breakthrough by enhancing cells. The bioeconomy field is attracting global attention, and therefore cell evaluation is an essential technology. We will actively make use of J-GoodTech to grow faster by means of tie-ups with various companies.

[Company structure for market development/overseas expansion]
We are developing CHO cells for substance production that are also applicable to chemicals and biofuels. We are considering business alliances and tie-ups with companies willing to advance into the bioeconomy field in order to enter this new field. We are seeking sales alliances and tie-ups with material manufacturers. We anticipate they will commercialize our CHO cells for substance production, which are also applicable to chemicals and biofuels in the new bioeconomy field.

[Awards and media coverage]
The Chemical Daily, "Highly Efficient Production of Chemicals Using Cells" (May 9, 2017).

[Intellectual property]
Mouse artificial chromosome vector (Japanese Patent No. 5557217), and three other patients.

This company is recommended by the following support organizations.

Chugoku Head Office, SMRJ
Marketing Support Department, SMRJ